Oramed Pharmaceuticals stock price
오라메드 파머슈티컬스NASDAQ:ORMP · Nasdaq · Healthcare$4.49+0.22%
2026-10-02 closeLoading chart…
Today's signals · No active technical signal.
Signal details →Oramed Pharmaceuticals last closed at $4.49 (+0.22%) on 2026-10-02. Listed on Nasdaq. Trailing 12 months PER is 1.1×. Its overall grade ranks 54 of 739 stocks in Healthcare.
About this company
Oramed Pharmaceuticals last closed at $4.49 (+0.22%) on 2026-10-02. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall A+ · 54/739
Valuation grade A+
Related stocks
- Novo NordiskCompetitor
경구용 당뇨·비만 치료제 개발에서 경쟁하는 글로벌 대형 제약사
- Eli LillyCompetitor
당뇨·비만 치료제 시장의 핵심 경쟁사
- PfizerCompetitor
경구 단백질/펩타이드 및 당뇨 치료제 개발 측면에서 비교되는 대형 제약사
About Oramed Pharmaceuticals
- What technical signals does Oramed Pharmaceuticals (ORMP) have?
- Oramed Pharmaceuticals current technical signals: no active technical signal.
- Is Oramed Pharmaceuticals a cup-and-handle pattern?
- No. Oramed Pharmaceuticals has no valid Cup signal right now.
- What published figures are available for Oramed Pharmaceuticals?
- Market cap: $191.66M. Trailing 12 months PER: 1.1×. Latest quarter PBR: 0.60×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Oramed Pharmaceuticals, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.
Quantus Signal · live data · not investment advice · Privacy Policy